RATIONALE: Diagnostic procedures, such as anal swab collection, digital rectal examination, and anal endoscopy and biopsy, may help find and diagnose anal and genital human papillomavirus infection and squamous intraepithelial lesions and help doctors plan better treatment. PURPOSE: This clinical trial is studying ways to detect anal and genital human papillomavirus infection and squamous intraepithelial lesions in HIV-positive patients enrolled in an AIDS cancer clinical trial.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Activity of pharmacotherapeutic agents being investigated in AIDS Malignancy Clinical Trials (AMC) against anogenital human papillomavirus (HPV) infection or anogenital squamous intraepithelial lesions (ASIL)
Timeframe: Baseline, every 6 months while on parent protocol, treatment discontinuation on parent protocol, final visit on parent protocol
Cervical HPV infection and cervical/vulvovaginal disease in women participating in AMC clinical trials
Timeframe: Baseline, every 6 months while on parent protocol, treatment discontinuation on parent protocol, final visit on parent protocol
Changes in cervical HPV infection and cervical/vulvovaginal disease after treatment on AMC studies
Timeframe: Baseline, every 6 months while on parent protocol, treatment discontinuation on parent protocol, final visit on parent protocol
Changes in anal HPV types present
Timeframe: Baseline, every 6 months while on parent protocol, treatment discontinuation on parent protocol, final visit on parent protocol
Frequency of ASIL
Timeframe: Baseline, treatment discontinuation on parent protocol, final visit on parent protocol